Immunoblotting and Goldmann-Witmer Coefficient for Ocular Toxoplasmosis

计划入组 87 人 · 首次发布于 2019 年 5 月 14 日

Spectral Optical Coherence Tomography Findings in Patients With Ocular Toxoplasmosis

计划入组 9 人 · 首次发布于 2020 年 1 月 6 日

Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis

计划入组 141 人 · 首次发布于 2011 年 10 月 10 日

ShK-Ocular

Ocular Extractives

NSAID ocular implant

Ocular Therapeutix

United States

Ocular Therapeutix, Inc.

United States

Refocus Group, Inc.

United States

Experts Call for WHO to Recognize Ocular Toxoplasmosis as a Neglected Tropical Disease

FDA Aligns with Signal12 on Phase 3 Trial Design for Novel Ocular GVHD Therapy Pro-ocular

VisiRose Secures $3 Million Seed Funding to Advance Rose Bengal-Based Ocular Therapeutics